Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PR-Bio, also known as Precision Research Bio, is a biotechnology company and contract research organization (CRO) specializing in high-throughput proteomics and mass spectrometry services. The company provides advanced analytical solutions to pharmaceutical and academic partners, focusing on deep protein profiling and biomarker discovery. By leveraging proprietary workflows and state-of-the-art instrumentation, PR-Bio enables the quantification of thousands of proteins across large sample cohorts with high precision. Their services are designed to accelerate drug development and clinical research by providing comprehensive insights into the proteome. The company is positioned as a key player in the precision medicine space, offering scalable proteomics to support therapeutic discovery and development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PR Bio.